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Atrial natriuretic peptide (ANP) is a potent inhibitor of
agonist-induced aldosterone synthesis in zona glomeru-
losa (ZG) cells of the adrenal gland. Cellular ANP effects
are mediated by two receptors: GC-A, a membrane guan-
ylyl cyclase, and GC-C that lacks guanylyl cyclase activity.
To identify which one of these two receptors is involved in
inhibitory pathway of aldosterone production we devel-
oped a new model of isolation and primary culture of
mouse ZG cells. Aldosterone concentration in the blood
was not different in wild type and GC-A knockout mice.
ANP (10 nM) significantly inhibited basal, forskolin, and
Angiotensin II-stimulated aldosterone production from
wild type mice, while in GC-A knockout mice ANP had no
inhibitory effect on aldosterone production. Inhibition of
forskolin or ACTH stimulated aldosterone production by
ANP was connected with increased concentration of
cGMP, stimulation of cGMP-stimulated phosphodieste-
rase (PDE2), and decrease of intracellular cAMP content.
IBMX and the PDE2-selective inhibitor MEP-1 completely
prevented ANP inhibitory effect on cAMP-stimulated
aldosterone production. In contrast, ANP-dependent
inhibition of Ang II-stimulated aldosterone production
was not connected with PDE2 or PKG activity indicating
that other cGMP-dependent mediator(s)/mechanism(s)
are involved in regulation of Ang II-stimulated aldoster-
one production from ZG cells by cGMP.
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